CJC 1295 vs Ipamorelin
Evidence tier, human-evidence strength, regulatory status, and hype-vs-data — side by side.
CJC 1295 and Ipamorelin grade similarly on current evidence — the right read depends on goal, regulatory status, and risk tolerance.
- Stronger human evidence: comparable
- More hype than data: neither stands out
| cjc-1295 | ipamorelin | |
|---|---|---|
| Class | Growth-hormone secretagogues | Growth-hormone secretagogues |
| Regulatory status | Research-use-only | Research-use-only |
| Candidate sources | 0 | 0 |
| Top study types (candidate) | — | — |
| Translation risk | pending review | pending review |
CJC 1295 vs Ipamorelin: FAQ
Is CJC 1295 better than Ipamorelin?
CJC 1295 and Ipamorelin grade similarly on current evidence — the right read depends on goal, regulatory status, and risk tolerance. Neither is a recommendation to use anything; this compares the state of the evidence only.
What's the difference between CJC 1295 and Ipamorelin?
CJC 1295 is research-use-only and sits at the “Animal” evidence stage; Ipamorelin is research-use-only and sits at “Animal.”
Which has stronger human evidence, CJC 1295 or Ipamorelin?
Both have comparable human-evidence levels on our scale.
Research reference only. Not medical advice, treatment instructions, or a purchase recommendation. Consult a licensed professional.